VYNE THERAPEUTICS INC's ticker is VYNEXXXX and the CUSIP is 92941V100. A total of 106 filers reported holding VYNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 2,000,000 | $3,160,000 | 10.65% |
| DSC Advisors, L.P. | 4,152,580 | $6,561,000 | 5.42% |
| CM Management, LLC | 644,198 | $1,018,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 2,095,400 | $3,311,000 | 0.51% |
| 683 Capital Management, LLC | 5,968,957 | $9,431,000 | 0.45% |
| Perceptive Advisors | 22,876,410 | $36,145,000 | 0.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 349,624 | $552,000 | 0.32% |
| Saltoro Capital, LP | 361,497 | $571,000 | 0.28% |
| Platform Technology Partners | 96,829 | $153,000 | 0.08% |
| FIRST MIDWEST BANK TRUST DIVISION | 297,912 | $471,000 | 0.07% |